GEN
GENOMED NEWCONNECT LISTED

Shareholders

as of August 13, 2026 · source: notifications under Art. 69 of the Offering Act · 6 entities above 5% of votes

FREE FLOAT
14.07%
185,956 shares
LARGEST STAKE
41.17%
Diagnostyka S.A.
TOP 3 CONCENTRATION
70.42%
3 entities above 5% of votes
LATEST CHANGE
June 30, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 1,321,301 (report, Aug 13, 2026)
SHAREHOLDERS ≥5% OF VOTES 85.93% FREE FLOAT 14.07%
Diagnostyka S.A. 41.17%
543,963 shares NOTIFICATION: Aug 13, 2026
Marek Zagulski 20.07%
265,228 shares NOTIFICATION: Aug 13, 2026
Anna Boguszewska-Chachulska 9.18%
121,236 shares NOTIFICATION: Aug 13, 2026
Iwona Wach 5.6%
74,000 shares NOTIFICATION: Aug 13, 2026
Andrzej Migdalski 4.96%
65,498 shares NOTIFICATION: Aug 13, 2026
Andrzej Pałucha 4.95%
65,420 shares NOTIFICATION: Aug 13, 2026
Other 14.07%
185,956 shares composition undisclosed

Capital and votes

Number of shares
1,321,301
ISIN
PLGNOMD00024
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.